New Option for Erasing Wrinkles( Dysport®...),Health

Dysport® cosmetic injection receives U.S. FDA Approval

(Vocus) June 4, 2009-- A new wrinkle-smoother will be arriving in doctors' offices in July: the U.S. FDA has approved the cosmetic injectable Dysport®. Dysport®, approved in the European Union, Brazil, Argentina and more than 26 countries worldwide is a form of botulinum type A, similar to the protein found in Botox® Cosmetic, approved for fighting wrinkles in the U.S. since 2004. Dysport® and Botox® are both cosmetic injections that temporarily relax the muscles in the face that create expressions, such as frown lines between the brows, that over time result in visible facial lines and deeper creases. "Although their action is similar, Dysport® and Botox® Cosmetic are two different drugs," said oculoplastic surgeon Dr. Brian Biesman, Coalition leader and Assistant Clinical Professor at Vanderbilt University Medical Center in Nashville, TN. "Both temporarily modify the action of facial muscles, smoothing out undesirable lines between the brows, across the forehead or crow's feet to restore a more youthful, less stressed appearance. But they are not interchangeable, they have distinct dosing differences."

"Cosmetic injections of any kind require examination, the informed consent process and prescription, including the proper dose, by a qualified board-certified plastic surgeon, facial plastic surgeon, oculoplastic surgeon or dermatologist, to achieve both a visually pleasing and a safe outcome. The doctor you choose should also either provide the injection or directly supervise the registered nurse (R.N) or physician's assistant (P.A.) who will inject you," said plastic surgeon and Coalition leader Mark Codner, MD, of Atlanta, GA. "In my practice, I inject all my patients personally. You have the right to request that your doctor perform the injection if you
'/>"/>